| Affiliation: | 1. From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, and the Joint Program in Transfusion Medicine, Department of Medical Oncology, Dana‐Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;2. the Division of Laboratory Medicine, Nevada Cancer Institute, Las Vegas, Nevada;3. the Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine, Singapore;4. and the Harvard Stem Cell Institute, Center for Life Science, Boston, Massachusetts. |
